Additional traditional Chinese medicine on gastrointestinal dysfunction in patients with sepsis: A systematic review and meta-analysis

被引:3
作者
Zhang, Yajing [1 ,2 ]
Zhao, Zhiqiang [2 ]
Tang, E. [2 ]
Hu, Yucai [3 ]
Mao, Jingyuan [2 ]
机构
[1] Zhengzhou Hosp Tradit Chinese Med, Zhengzhou, Peoples R China
[2] Tianjin Univ Tradit Chinese Med, Teaching Hosp 1, Tianjin, Peoples R China
[3] Henan Coll Tradit Chinese Med, Teaching Hosp 1, Zhengzhou, Peoples R China
关键词
Traditional chinese medicine; sepsis; gastrointestinal dysfunction; systematic review;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
To evaluate the clinical effect and safety of western medicine plus Traditional Chinese medicine for sepsis with gastrointestinal dysfunction. We searched CNKI (January 1979 to June 2014), VIP (January 1989 to June 2014), CBM (1978 to 2014), Wan Fang DATA (January 1990 to June 2014), PubMed (1978 to June 2014), The Cochrane Library (Issue 5, 2014), Embase (1974 to June 2014), and other relevant databases and journals to identify randomized controlled trials (RCTs) on western medicine plus Traditional Chinese medicine versus western medicine only for sepsis with gastrointestinal dysfunction. The methodological quality was assessed and the data was extracted according to the Cochrane Reviewer's Handbook and related methods. Meta-analyses were performed by RevMan 5.1.0 software. Five eligible studies included 278 patients. The results of meta-analyses showed that western medicine plus Traditional Chinese medicine therapy can improve the APACHEII score, the peristaltic sound score and SIRS score, improve abdominal distension, decreased white blood cell count, reduce DAO in sepsis patients with gastrointestinal dysfunction. 3 studies reported adverse reactions, there was no significant difference between two groups. Western medicine plus Traditional Chinese medicine can improve gastrointestinal dysfunction in sepsis.
引用
收藏
页码:663 / 669
页数:7
相关论文
共 16 条
[1]  
[Anonymous], REV MAN REVMAN COMP
[2]   AMERICAN-COLLEGE OF CHEST PHYSICIANS SOCIETY OF CRITICAL CARE MEDICINE CONSENSUS CONFERENCE - DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ ;
ABRAMS, JH ;
BERNARD, GR ;
BIONDI, JW ;
CALVIN, JE ;
DEMLING, R ;
FAHEY, PJ ;
FISHER, CJ ;
FRANKLIN, C ;
GORELICK, KJ ;
KELLEY, MA ;
MAKI, DG ;
MARSHALL, JC ;
MERRILL, WW ;
PRIBBLE, JP ;
RACKOW, EC ;
RODELL, TC ;
SHEAGREN, JN ;
SILVER, M ;
SPRUNG, CL ;
STRAUBE, RC ;
TOBIN, MJ ;
TRENHOLME, GM ;
WAGNER, DP ;
WEBB, CD ;
WHERRY, JC ;
WIEDEMANN, HP ;
WORTEL, CH .
CRITICAL CARE MEDICINE, 1992, 20 (06) :864-874
[3]   Polymyxin B for endotoxin removal in sepsis [J].
Cavaillon, Jean-Marc .
LANCET INFECTIOUS DISEASES, 2011, 11 (06) :426-427
[4]  
Critically care expert committee of emergency medicine branch of chinese medical association emergency medicine professional committee of Chinese association of integrative medicine, 2007, CJEM, V6, P797
[5]  
Dellinger RP, 2008, CRIT CARE MED, V36, P1394
[6]  
HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001
[7]  
Shi Bian, 2012, MASTER 2 MILITARY ME, V33, P1213
[8]  
Su Yujie, 2013, MIICWM, V22, P1762
[9]  
Su Yujie, 2013, MIICWM, V22, P1737
[10]  
Wang JD, 1995, CHINESE CRITICAL CAR, V7, P346